Evidence map›Paper›PMID 42487275›Full record

ArticleDrug delivery2026

Development and

Thabata Muta, Songhita Mukhopadhyay, Benjamin Noll, Yunmei Song, Sanjay Garg

Abstract read
In one paragraph

Article in Drug delivery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Thabata MutaSchool of Pharmacy and Biomedical Sciences, Adelaide University, Adelaide, SA, Australia.
Songhita MukhopadhyaySchool of Pharmacy and Biomedical Sciences, Adelaide University, Adelaide, SA, Australia.
Benjamin NollSchool of Pharmacy and Biomedical Sciences, Adelaide University, Adelaide, SA, Australia.
Yunmei SongSchool of Pharmacy and Biomedical Sciences, Adelaide University, Adelaide, SA, Australia.
Sanjay GargSchool of Pharmacy and Biomedical Sciences, Adelaide University, Adelaide, SA, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cannabidiol (CBD) exhibits poor oral bioavailability (approximately 6%) due to low solubility and excessive first-pass metabolism, limiting its therapeutic potential. This study introduces a novel phospholipid complex self-nanoemulsifying drug delivery system (CBD-PLC-SNEDDS) to enhance CBD delivery. CBD-PLC was integrated into an optimized SNEDDS

Indexed as

CannabidiolDrug Delivery SystemsNanoparticle Drug Delivery SystemNanoparticlesPhospholipidsAdministration, OralAnimalsBiological AvailabilityChemistry, PharmaceuticalDrug LiberationDrug StabilityEmulsionsMaleParticle SizeRatsRats, Sprague-DawleyCannabidiolEmulsionsNanoparticle Drug Delivery SystemPhospholipidsCannabidioloral bioavailabilitypharmacokineticsphospholipid complexself-nanoemulsifying drug delivery system

Identifiers

PMID42487275
PMCPMC13398106

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.